Omeros Corporation (OMER)
NASDAQ: OMER
· Real-Time Price · USD
3.35
-0.05 (-1.47%)
At close: Jun 16, 2025, 3:59 PM
3.39
1.04%
After-hours: Jun 16, 2025, 06:15 PM EDT
-1.47% (1D)
| Bid | 3 |
| Market Cap | 196.58M |
| Revenue (ttm) | 412K |
| Net Income (ttm) | -153.09M |
| EPS (ttm) | -3.04 |
| PE Ratio (ttm) | -1.1 |
| Forward PE | -59 |
| Analyst | Buy |
| Ask | 3.69 |
| Volume | 601,669 |
| Avg. Volume (20D) | 974,380 |
| Open | 3.28 |
| Previous Close | 3.40 |
| Day's Range | 3.28 - 3.45 |
| 52-Week Range | 2.97 - 13.60 |
| Beta | 2.20 |
About OMER
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OMER
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OMER stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+3.89%
Omeros shares are trading after the company announ...
Unlock content with
Pro Subscription
5 months ago
+37.27%
Omeros shares are trading higher after the company announced that narsoplimab met its primary trial endpoint and will resubmit its narsoplimab Biologics License Application to the FDA.
